Brian Piekos

Insider Reports History

Location
Waltham, MA
Signature
/s/ Benjamin L. Palleiko, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Brian Piekos:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Gemini Therapeutics, Inc. /DE CFO Common Stock 17.6K $1.19M $67.65 May 31, 2022 Direct
KalVista Pharmaceuticals, Inc. Chief Financial Officer Restricted Stock Unit 65K $786K $9.82 Nov 21, 2025 Direct
KalVista Pharmaceuticals, Inc. Chief Financial Officer Common Stock 10.5K $142K $13.45 Nov 24, 2025 Direct
Gemini Therapeutics, Inc. /DE CFO Restricted Stock Units 281K Jan 13, 2022 Direct
Elicio Therapeutics, Inc. Chief Financial Officer Stock Option (right to buy) 43.2K Feb 1, 2024 Direct

Insider Reports Filed by Brian Piekos

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KALV KalVista Pharmaceuticals, Inc. Nov 21, 2025 3 -$60.1K 4 Nov 26, 2025 Chief Financial Officer
KALV KalVista Pharmaceuticals, Inc. Feb 21, 2025 1 $0 4 Feb 25, 2025 Chief Financial Officer
KALV KalVista Pharmaceuticals, Inc. Sep 9, 2024 1 $0 4 Sep 11, 2024 Chief Financial Officer
KALV KalVista Pharmaceuticals, Inc. Sep 9, 2024 0 $0 3 Sep 11, 2024 Chief Financial Officer
ELTX Elicio Therapeutics, Inc. Feb 1, 2024 1 $0 4 Feb 5, 2024 Chief Financial Officer
ELTX Elicio Therapeutics, Inc. Jun 1, 2023 1 $0 4 Jun 5, 2023 Chief Financial Officer
ELTX Elicio Therapeutics, Inc. Jun 1, 2023 0 $0 3 Jun 5, 2023 Chief Financial Officer
IRON Gemini Therapeutics, Inc. /DE May 31, 2022 1 $10.9K 4 Jun 2, 2022 CFO
IRON Gemini Therapeutics, Inc. /DE Jan 13, 2022 1 $0 4 Jan 14, 2022 CFO
IRON Gemini Therapeutics, Inc. /DE Oct 18, 2021 1 $0 4 Oct 20, 2021 Chief Financial Officer
IRON Gemini Therapeutics, Inc. /DE May 14, 2021 1 $72.4K 4 May 18, 2021 Chief Financial Officer